Cost ‐effectiveness of liposomal amphotericin B in hospitalised patients with mucocutaneous leishmaniasis

ConclusionsIn the treatment of mucocutaneous leishmaniasis, L‐AmB is a cost‐effective alternative to SbV and AmB‐D owing to its higher effectiveness, safety and shorter course.

Source: Tropical Medicine and International Health - November 22, 2017 Category: Tropical Medicine Authors: S óstenes Mistro, Bárbara Gomes, Lorena Rosa, Ligia Miranda, Marianne Camargo, Roberto Badaró Tags: Original Article Source Type: research